Trial
NCT04205136
Spironolactone to Improve Apnea and Cardiovascular Markers in Obstructive Sleep Apnea Patients
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Michigan
Collaborators
—
Condition
Obstructive Sleep Apnea
Intervention
Spironolactone
Why stopped
Was on hold due to Covid then we were not able to initiate the funding again after such a long hold and loss of team members.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-19